Joe Renda
Analyst
Commercial Leader, Specialty
Analyst
Specialty Lead
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Joe Renda
Joe Renda is recorded as Analyst at Commercial Leader, Specialty and Analyst at Specialty Lead. Joe Renda has spoken on 2 earnings calls across 1 company, most recently for Amneal Pharmaceuticals, Inc. on August 5, 2025.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Amneal Pharmaceuticals, Inc. (AMRX)
Source not stated
Current -
Commercial Leader, Specialty
Analyst
Source not stated
Current -
Halozyme Therapeutics, Inc. (HALO)
Source not stated
Current -
Specialty Lead
Analyst
Source not stated
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Amneal Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- Chintu Patel CEO, Board Member
- Chirag Patel CEO, Board Member
- Paul Meister Chairman, Board Member
- Anastasios (Tasos) G. Konidaris CFO
- Anastasios Konidaris CFO
- Stephen J. Manzano General Counsel
- Deb Autor Board Member
- Deborah M. Autor Board Member
- Gautam Patel Board Member
- J. Kevin Buchi Board Member
Leadership on record at Halozyme Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Helen Torley CEO, Board Member
- Darren Snellgrove CFO
- Elaine D. Sun CFO
- Nicole LaBrosse CFO
- Cortney Caudill COO
- Mark Snyder General Counsel
- Barbara Duncan Board Member
- Bernadette Connaughton Board Member
- Connie L. Matsui Board Member
- Dannielle Appelhans Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.